BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37646829)

  • 1. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.
    Huang H; Xu S; Ni S; Liu W; Liu S
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15525-15533. PubMed ID: 37646829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.
    Lin Y; Cui N; Li F; Wang Y; Wang B
    Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
    Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
    Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
    Zhao L; Sun X; Luo Y; Wang F; Lyu Z
    Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prediction model for identifying high-risk lymph node metastasis in clinical low-risk papillary thyroid microcarcinoma.
    Huang H; Liu Y; Ni S; Liu S
    BMC Endocr Disord; 2023 Nov; 23(1):260. PubMed ID: 38012653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.
    Qu N; Zhang L; Lin DZ; Ji QH; Zhu YX; Wang Y
    Tumour Biol; 2016 Jun; 37(6):7685-92. PubMed ID: 26692097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
    Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
    He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
    Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
    Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
    Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
    Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for central lymph node metastasis in papillary thyroid microcarcinoma - a retrospective study of 1433 cases from a single center.
    Shen Y; Pu W; Zhou H; Cui M; Zhao W; Ma J; Wang C; Sun Z
    Pol J Pathol; 2022; 73(3):191-197. PubMed ID: 36734433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
    Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
    Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.
    Yang Z; Wang X; Tao T; Zou J; Qiu Z; Wang L; Du H; Chen N; Yin X
    BMC Surg; 2023 Oct; 23(1):325. PubMed ID: 37875825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
    Wei B; Yao J; Peng C; Zhao S; Wang H; Wang L; Zhu X; Kong Y; Chen L; Xu D
    BMC Cancer; 2023 Dec; 23(1):1225. PubMed ID: 38087256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
    Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
    Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.